Tag Archive
OncoGenex Pharmaceuticals to pay Isis Pharmaceuticals $10M for license of OGX-011 to Teva Pharmaceutical Industries (News-Medical-Net)
Isis Pharmaceuticals, Inc. today announced that it will receive a $10 million payment from OncoGenex Pharmaceuticals, Inc. as a result of OncoGenex’ license of OGX-011 to Teva Pharmaceutical Industries Ltd. ( TEVA). OGX-011 is a second-generation antisense drug co-discovered by Isis and OncoGenex that has completed a successful Phase 2 program in patients with... »
Detecting the Undetectable in Prostate Cancer Testing (PhysOrg)
(PhysOrg.com) — A team of Northwestern University researchers, using an extremely sensitive nanotechnology-based tool known as the biobarcode system, has detected previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical prostatectomy. This new assay, just one of many being developed by investigators at the Nanomaterials for Cancer Diagnostics and … (read... »
Gold Nanoparticles Could Detect Disease (Discovery Channel)
Modified nanoparticles that can identify prostate cancer could track a wide variety of diseases. (get the story…) Related items Scientists creating ‘golden bullet’ for cancer (Sify News) Scientists creating ‘golden bullet’ for cancer (New Kerala) Using gold nanoparticles to hit cancer where it hurts (Science Daily) Prostate Cancer Recurrence Detected Early in Nanosphere Test (Bloomberg) Diagnosing lung cancer through a simple... »
Nano-PSA test detects prostate cancer relapse (Press TV)
A new nanotechnology-based test can predict the come back of prostate cancer in men who have already undergone prostate surgery. (read here…) Related items New Test Checks for Prostate Cancer Return (WebMD) PSA ‘Nanotest’ May Spot Prostate Cancer’s Return After Surgery (HealthDay via Yahoo! News) OncoGenex Pharmaceuticals to pay Isis Pharmaceuticals $10M for license of OGX-011 to Teva Pharmaceutical... »
PSA ‘Nanotest’ May Spot Prostate Cancer’s Return After Surgery (HealthDay via Yahoo! News)
MONDAY, Oct. 19 (HealthDay News) — A new test that could revolutionize the treatment of men following prostate cancer surgery has worked well in a small, early trial, researchers report. (read here…) Related items Nano-PSA test detects prostate cancer relapse (Press TV) New Test Checks for Prostate Cancer Return (WebMD) Prostate Cancer Recurrence Detected Early in Nanosphere Test (Bloomberg) Research... »
